We developed a new Neisseria meningitidis multiplex PCR to determine six serogroups, including X-specific primers, and to allow direct W135/Y discrimination. This assay offers a simple and low-cost method for serogrouping N. meningitidis from cerebrospinal fluid that could be useful in Africa.
gene cassette required for the biosynthesis of the capsule of serogroup A (13) in the synD and synE genes encoding the polysialyltransferase responsible for the polymerization of polymers of sialic acid containing polysaccharides in strains belonging to serogroups B and C, respectively, and in the synF and synG genes, encoding proteins that catalyze the linkage of sialic acid with other sugars in the polysaccharide chains of serogroups Y and W135, respectively (6, 10) ; these primers were those described by Taha (14) . The sizes of the expected amplicons are 450 bp (B), 400 bp (A), 250 bp (C), and 120 bp (W135). For direct identification of serogroup Y, the reverse primer in the synF gene was identical to that previously described (14) , but a new forward primer in the synF gene was designed to amplify a Y-specific 75-bp product, distinct from the 120-bp W135-specific amplicon. The 3Ј end of the crtA gene, which encodes an outer membrane protein involved in capsule transport, is highly conserved among meningococci irrespective of serogroups, but the 5Ј end is very variable (7) . Both forward and reverse primers specific to serogroup X were then designed within this variable region, giving rise to a serogroup X-specific 190-bp amplification product ( Table 1) .
The aim of this study was to assess this multiplex PCR assay using DNA extracted either directly from CSF samples (n ϭ 13) or from CSF-isolated meningococcal strains (n ϭ 32). Some strains were also obtained from blood (n ϭ 2), expectoration (n ϭ 1), or pharyngeal carriage (n ϭ 1). The biological source of one sample was not provided. A previous serogroup determination had been performed by agglutination tests (Pastorex and/or Difco) or previous PCR analyses as follows: A (n ϭ 9), B (n ϭ 8), C (n ϭ 4), X (n ϭ 11), W135 (n ϭ 12), and Y (n ϭ 7). Strains belonging to other bacterial species responsible for meningitis, Haemophilus influenzae (n ϭ 5) or Streptococcus pneumoniae (n ϭ 5), were used as negative controls. Neisseria meningitidis samples are listed in Table 2 , also indicating the origin (country, source) and the genotype determined by MLST analysis (sequence type [ST] ). Strains belonging to different STs within one serogroup were chosen when data were available.
Bacterial DNA was isolated using the High Pure PCR template kit (Roche), by following the manufacturer's instructions, directly from CSF samples or from colonies isolated on bloodagar plates. For serogrouping, the amplification reaction was performed on 50 ng DNA using primers specific to groups A, B, C, W135, Y, and X ( Table 2 ). The reaction was performed in a 25-l final volume comprising 1 U GoldStar Red DNA polymerase (Eurogentec), 1ϫ polymerase buffer, 300 nM of each primer, 200 nM of each deoxynucleoside triphosphate (Roche), and 2.5 mM MgCl 2 . The PCR cycles were as follows: denaturation at 94°C for 5 min; amplification at 94°C for 30 s, 55°C for 30 s, and 72°C for 45 s for 35 cycles; and 72°C for 10 min. Amplification products were visualized on a 4% agarose gel stained with ethidium bromide so that those with small sizes could be easily separated.
The multiplex PCR described here perfectly determined the serogroup of N. meningitidis in all the samples analyzed ( Fig.  1) . No amplification could be observed with the other bacterial species used in this study. Each sample showed one single specific amplification product, which makes the results of our PCR easy to read, compared to the recent multiplex PCR reported by Bennett et al. (2) showing multiple bands.
We particularly demonstrate that this multiplex PCR allows (i) the direct distinct discrimination between serogroups W135 and Y, using the new forward Y-specific primer in the synF gene, and (ii) the specific identification of serogroup X strains with new primers in the 5Ј end of the ctrA gene.
Although this PCR included oligonucleotides specific to serogroups B and C, the goal of this study was particularly to develop a rapid, simple, and low-cost standard multiplex PCR that could be easily used in African countries for the determination of the main serogroups encountered in the meningitis belt. Thus, this PCR was particularly designed to directly distinguish between W135 and Y serogroups so that it would be more convenient. Comparison of the nucleotide sequences of the synG and synF genes of W135 and Y strains, respectively (GenBank accession numbers AY234196 and AY234201), shows that the only variable region is located within the 120-bp sequence corresponding to the W135/Y amplicon obtained with the primers described by Taha (14) . Since these specific primers show only about a 30% difference, we looked within this 120-bp region to find a possible oligonucleotide that could be used as another W135-or Y-specific primer, giving rise to an amplicon of a smaller size. We then designed the new Y-specific 5Ј primer, 98-36, leading to the amplification of a 75-bp product, in combination with the 3Ј Y-specific primer, 98-35. Figure 1 shows that W135-and Y-specific amplicons can be easily discriminated on a 4% agarose gel. The nucleotide sequence of this new forward Y-specific primer showed only 26% difference from the corresponding W135 sequence; it had been first tested in single PCR analyses associated with either the reverse Y primer, 98-35, or the reverse W135 primer, 98-33, and was shown to be effectively Y specific (not shown).
Moreover, due to the recent emergence of meningococcus X outbreaks (3, 5, 8) , we also focused on the use of a multiplex PCR assay that could be able to identify serogroup X strains in biological samples. As already mentioned above, the aim was to develop this multiplex PCR for African countries, meaning that it needs to be simple, rapid, and low cost. It was then necessary to also include X-specific primers. Primers previously described (1) were shown to work at 62.5°C, generating a 525-bp amplicon, but could also amplify a 650-bp product for some serogroup A strains, albeit different from the X-specific product and from the 400-bp A-specific amplicon obtained with the orf-2 primers (Table 1 ). Since our PCR was based on an annealing temperature of 55°C, we designed new forward and reverse X-specific primers using the Primer3 v0.4.0 program (http://frodo.wi.mit.edu/) so that they amplify a product with a distinguishable size at 55°C. The two oligonucleotides, XF and XR, were chosen within the 5Ј end of the ctrA gene (GenBank accession number AY289931), which was reported to be very variable and group specific (7), and generated a 190-bp amplicon. We demonstrate here that these two oligonucleotides amplified a serogroup X-specific product (Fig. 1) and that primers can be chosen within the 5Ј variable crtA region for serogroup determination.
As shown in Table 2 , the identification of the serogroup with our PCR is in agreement with the previous serogroup determination obtained by agglutination assays. Interestingly, the multiplex PCR allowed the serogroup determination of two samples, 2008-183 and 2007-443, which presented a polyagglutination status. Thus, it confirms that serogrouping by PCR could be helpful when agglutination tests fail or when culture is negative or not available. Indeed, we show that the multiplex PCR worked perfectly on DNA extracted directly from the CSF samples (n ϭ 13) included in our study (Table 2) , particularly those from Togo collected in 2008 (serogroups X and W135). These samples were indeed also part of another recent study in which serogroup X Neisseria meningitidis (ST 181) was reported to cause substantial disease in central Togo (on the border of the meningitis belt) during 2007 and 2008 (11) , suggesting that the earlier serogroup X N. meningitidis out- (3) were not localized events but had expanded to surrounding areas. The recent report on the high prevalence of serogroup X carriage among children in northern Ghana also strongly suggests the need for surveillance of this potentially epidemic variant (8) . Additionally, serogroup X N. meningitidis has also recently been reported as being involved in an outbreak of meningococcal disease in western Kenya, outside the meningitidis belt, highlighting the presence of serogroup X in East Africa (9) . The emergence of serogroup X meningococcal clones in the various countries that make up the African meningitidis belt might lead to a potential epidemic in place of or in addition to serogroup A epidemics, as it was seen with the expansion of serogroup W135 (15) . Thus, the identification of serogroup X strains, in addition to the other serogroups, is of particular importance in African countries, pointing out the need for efficient diagnosis tools to detect the causative agent of acute bacterial meningitis in order to adapt the most appropriate treatment or preventive strategies. The multiplex PCR reported here could be such an helpful tool for laboratories in Africa, allowing low-cost, rapid, simple, and efficient prediction of the six main serogroups; if necessary, this PCR might be possibly more adapted to Africa by using only primers specific to serogroups A, W135, X, and Y, which are the four serotypes encountered most frequently in this part of the world. 8) , B (lanes 9 to 17), C (lanes 18 to 21) (A) and X (lanes 22 to 31) and W135 (lanes 32 to 43) and Y (lanes 44 to 50) (B). DNA from other species, Haemophilus influenzae (lanes 51, 52, 54, 55, 57) and Streptococcus pneumoniae (lanes 53, 56, 58, 59, and 60), were used as negative controls. PCR products were separated on a 4% agarose gel. Molecular sizes are indicated.
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